Arch Biopartners Inc (ARCH) - Total Assets

Latest as of March 2026: CA$463.16K CAD ≈ $335.04K USD

Based on the latest financial reports, Arch Biopartners Inc (ARCH) holds total assets worth CA$463.16K CAD (≈ $335.04K USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Arch Biopartners Inc - Total Assets Trend (1997–2025)

This chart illustrates how Arch Biopartners Inc's total assets have evolved over time, based on quarterly financial data. Also see Arch Biopartners Inc market capitalisation for the company's overall valuation and market capitalisation.

Arch Biopartners Inc - Asset Composition Analysis

Current Asset Composition (September 2025)

Arch Biopartners Inc's total assets of CA$463.16K consist of 100.0% current assets and 0.0% non-current assets. Review ARCH current and long-term liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$0.00	2.0%
Accounts Receivable	CA$0.00	0.0%
Inventory	CA$0.00	0.0%
Property, Plant & Equipment	CA$0.00	0.0%
Intangible Assets	CA$0.00	0.0%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (1997–2025)

This chart illustrates how Arch Biopartners Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Arch Biopartners Inc for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Arch Biopartners Inc's current assets represent 100.0% of total assets in 2025, an increase from 3.5% in 1997.
Cash Position: Cash and equivalents constituted 2.0% of total assets in 2025, up from 1.3% in 1997.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 11.0% in 1997.
Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

Arch Biopartners Inc Competitors by Total Assets

Key competitors of Arch Biopartners Inc based on total assets are shown below.

Company	Country	Total Assets
CSL Ltd AU:CSL	Australia	AU$39.54 Billion
Vaxcyte Inc NASDAQ:PCVX	USA	$3.14 Billion
Bachem Holding AG SW:BANB	Switzerland	CHF2.11 Billion
Definium Therapeutics, Inc. NASDAQ:DFTX	USA	$1.11 Billion
Chongqing Zhifei Bio Products SHE:300122	China	CN¥29.09 Billion
HLB Co. Ltd KQ:028300	Korea	₩925.44 Billion
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	China	CN¥6.82 Billion
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	China	CN¥3.16 Billion

Arch Biopartners Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.11	0.13	0.65
Quick Ratio	0.11	0.13	0.65
Cash Ratio	0.00	0.00	0.00
Working Capital	CA$-3.64 Million	CA$-3.77 Million	CA$-1.43 Million

Arch Biopartners Inc - Advanced Valuation Insights

This section examines the relationship between Arch Biopartners Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	6211.54
Latest Market Cap to Assets Ratio	427.81
Asset Growth Rate (YoY)	-88.8%
Total Assets	CA$104.53K
Market Capitalization	$44.72 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Arch Biopartners Inc's assets at a significant premium (427.81x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Arch Biopartners Inc's assets decreased by 88.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Arch Biopartners Inc (1997–2025)

The table below shows the annual total assets of Arch Biopartners Inc from 1997 to 2025.

Year	Total Assets	Change
2025-09-30	CA$104.53K ≈ $75.62K	-88.83%
2024-09-30	CA$935.62K ≈ $676.81K	-20.11%
2023-09-30	CA$1.17 Million ≈ $847.21K	+88.40%
2022-09-30	CA$621.64K ≈ $449.69K	-76.70%
2021-09-30	CA$2.67 Million ≈ $1.93 Million	+259.94%
2020-09-30	CA$741.30K ≈ $536.25K	+30.52%
2019-09-30	CA$567.98K ≈ $410.87K	-15.57%
2018-09-30	CA$672.69K ≈ $486.62K	+890.16%
2017-09-30	CA$67.94K ≈ $49.15K	-70.08%
2016-09-30	CA$227.03K ≈ $164.23K	-65.05%
2015-09-30	CA$649.50K ≈ $469.84K	+60.06%
2014-09-30	CA$405.79K ≈ $293.54K	+1001.91%
2013-09-30	CA$36.83K ≈ $26.64K	-60.75%
2012-09-30	CA$93.81K ≈ $67.86K	-57.75%
2011-09-30	CA$222.04K ≈ $160.62K	-58.52%
2010-09-30	CA$535.28K ≈ $387.22K	+33355.19%
2009-09-30	CA$1.60K ≈ $1.16K	-99.80%
2008-09-30	CA$797.32K ≈ $576.77K	-16.98%
2007-09-30	CA$960.41K ≈ $694.75K	+0.74%
2006-09-30	CA$953.38K ≈ $689.66K	-17.63%
2005-09-30	CA$1.16 Million ≈ $837.31K	-15.87%
2004-09-30	CA$1.38 Million ≈ $995.26K	-16.02%
2003-09-30	CA$1.64 Million ≈ $1.19 Million	+2668.41%
2002-09-30	CA$59.18K ≈ $42.81K	-16.12%
2001-09-30	CA$70.56K ≈ $51.04K	-97.02%
2000-09-30	CA$2.37 Million ≈ $1.71 Million	+87.01%
1999-09-30	CA$1.26 Million ≈ $914.95K	+575.79%
1998-09-30	CA$187.16K ≈ $135.39K	-47.71%
1997-09-30	CA$357.96K ≈ $258.94K	--

About Arch Biopartners Inc

V:ARCH Canada Biotechnology

Market Cap

$44.72 Million

CA$61.82 Million CAD

Market Cap Rank

#22400 Global

#798 in Canada

Share Price

CA$0.91

Change (1 day)

+2.25%

52-Week Range

CA$0.41 - CA$1.66

All Time High

CA$5.00